GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » Net Margin %

10x Genomics (MEX:TXG) Net Margin % : -23.58% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. 10x Genomics's Net Income for the three months ended in Sep. 2024 was MXN-704 Mil. 10x Genomics's Revenue for the three months ended in Sep. 2024 was MXN2,986 Mil. Therefore, 10x Genomics's net margin for the quarter that ended in Sep. 2024 was -23.58%.

The historical rank and industry rank for 10x Genomics's Net Margin % or its related term are showing as below:

MEX:TXG' s Net Margin % Range Over the Past 10 Years
Min: -181.61   Med: -32.15   Max: -11.87
Current: -28.99


MEX:TXG's Net Margin % is ranked worse than
82.42% of 660 companies
in the Healthcare Providers & Services industry
Industry Median: 2.19 vs MEX:TXG: -28.99

10x Genomics Net Margin % Historical Data

The historical data trend for 10x Genomics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Net Margin % Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -12.71 -181.61 -11.87 -32.15 -41.23

10x Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.52 -26.61 -42.52 -24.75 -23.58

Competitive Comparison of 10x Genomics's Net Margin %

For the Health Information Services subindustry, 10x Genomics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


10x Genomics's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Net Margin % distribution charts can be found below:

* The bar in red indicates where 10x Genomics's Net Margin % falls into.



10x Genomics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

10x Genomics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4330.114/10502.426
=-41.23 %

10x Genomics's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-703.987/2986.113
=-23.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


10x Genomics  (MEX:TXG) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


10x Genomics Net Margin % Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.